<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/116</identifier>
				<datestamp>2024-10-30T18:54:16Z</datestamp>
				<setSpec>aavptbiennial:SI</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Major Problem Areas in the New Animal Drug Approval Process</dc:title>
	<dc:creator xml:lang="en">Becker, Robert</dc:creator>
	<dc:subject xml:lang="en">FDA</dc:subject>
	<dc:subject xml:lang="en">regulatory body</dc:subject>
	<dc:subject xml:lang="en">regulation</dc:subject>
	<dc:subject xml:lang="en">drug testing</dc:subject>
	<dc:subject xml:lang="en">drug usage</dc:subject>
	<dc:description xml:lang="en">Industry complains that the approval process is both too long and too expensive. On the other hand, it would be hard to imagine any regulated industry which would not have that complaint about the manner in which it is being controlled. In any case, the optimum time and expense of any process is always relative to the objectives and values which are being protected by the process. There is no way that I, or anyone else, could prove, in the time we have this morning, whether FDA is or is not providing optimum protection at a minimal cost to industry and the public. I can, however, give my impressions and discuss what I believe the problems to be.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1982-04-13</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/116</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Third Symposium; 21-25</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/116/110</dc:relation>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/116/166</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1982 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
